News
One month before a stroke happens, please pay close attention to these signals because they could save your life. I have seen ...
Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.
A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...
DelveInsight's CD40/CD40L Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
A 40-year-old woman presents with a very itchy bilateral rash on her ankles and feet, present for a few months. She has a few ...
The company’s TYK2 inhibitor GLPG3667 sits on the chopping block as well. Galapagos is “actively exploring partnership ...
3d
Zacks Investment Research on MSNCartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?Cartesian Therapeutics, Inc. (RNAC) shares soared 9.9% in the last trading session to close at $13.39. The move was backed by solid volume with far more shares changing hands than in a normal session.
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.
Members of Citryll’s Scientific Advisory Board include: ...
Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...
In assessing the clinical benefit, the goal is not to determine if an eConsult can diagnose lupus, but instead to consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results